Opportunity Information: Apply for CDC RFA CI10 1004
Apply for CDC RFA CI10 1004
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Evidence Based Laboratory Medicine Quality/Performance Measure Evaluation" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.064 Laboratory Training, Evaluation, and Quality Assurance Programs.
- This funding opportunity was created on May 24, 2010 and posted on May 24, 2010.
- Applicants must submit their applications by Jul 7, 2010 Letter of Intent Deadline Date June 21, 2010 Application Submission Date July 2, 2010 (See full explanation in note found in Section V. Application Submission) Application Deadline Date July 7, 2010. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $2,250,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $350,000.00 in funding.
- The number of recipients for this funding is limited to 3 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Eligible applicants that can apply for this funding opportunity are listed below Nonprofit with 501C3 IRS status (other than institution of higher education) Nonprofit without 501C3 IRS status (other than institution of higher education) Universities Colleges Research institutions Hospitals Community based organizations Faith based organizations Federally recognized or state recognized American Indian/Alaska Native tribal governments American Indian/Alaska native tribally designated organizations Alaska Native health corporations Urban Indian health organizations Tribal epidemiology centers State and local governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau) Political subdivisions of States (in consultation with States) Other (specify) A Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application. If applying as a bona fide agent of a state or local government, a letter from the state or local government as documentation of the status is required. Attach with Other Attachment Forms when submitting via www.grants.gov.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Centers for Disease Control and Prevention (CDC) funding opportunity titled "Evidence Based Laboratory Medicine Quality/Performance Measure Evaluation" (Funding Opportunity Number CDC RFA CI10-1004) supported projects that aimed to improve the quality of clinical laboratory testing by developing and evaluating evidence-based quality or performance measures. The work was focused specifically on the parts of the laboratory testing process that happen before and after the actual analytic test run, meaning the pre-analytic stage (steps like ordering tests, collecting specimens, labeling, handling, transporting, and preparing samples) and the post-analytic stage (steps like reporting results, communicating critical values, interpreting and acting on results, and ensuring appropriate follow-up). The overall goal was to identify meaningful measures tied to real gaps in practice, then use those measures to drive practical quality improvement in healthcare delivery and to support consistent measurement and reporting of performance data.
A key feature of the opportunity was that applicants were expected to concentrate on one focused area that aligned with national healthcare priorities and had clear public health importance, rather than proposing broad, unfocused measurement across many laboratory domains. In other words, the CDC was looking for targeted, high-value measurement work where better performance tracking could plausibly lead to safer care, fewer errors, improved outcomes, or more efficient and reliable laboratory-supported clinical decision-making. The scope was explicitly limited to quality improvement associated with delivering healthcare, along with the measurement and reporting systems needed to monitor performance; it was not framed as basic science research, new test development, or unrelated laboratory infrastructure expansion.
This opportunity was offered as a discretionary cooperative agreement, which typically means the CDC anticipated substantial involvement during the project period (for example, providing technical input, alignment with national measurement frameworks, or coordination across awardees). The program planned to make about three awards, with an estimated total funding amount of $2,250,000. Individual awards were expected to fall between $150,000 and $350,000, reflecting a mid-sized funding level appropriate for measure development, evaluation, validation, and early implementation work rather than large-scale nationwide rollouts.
Eligibility was broad and included many organization types that could credibly conduct applied quality measurement and improvement work. Eligible applicants included nonprofits (with or without 501(c)(3) status), universities and colleges, research institutions, hospitals, community-based and faith-based organizations, tribal governments and tribal organizations (including Alaska Native health corporations, Urban Indian health organizations, and Tribal epidemiology centers), and state and local governments along with their political subdivisions. The announcement also allowed applications from bona fide agents applying on behalf of a state or local government, but required documentation (a letter from the relevant government entity) confirming that bona fide agent status when submitting through Grants.gov. No cost sharing or matching funds were required.
The timeline for the opportunity indicates it was posted on May 24, 2010, with a letter of intent due June 21, 2010, and an application submission date of July 2, 2010, with the formal closing date and application deadline listed as July 7, 2010. The opportunity was later archived on August 6, 2010, meaning it was a time-limited competition and is no longer open. For applicants needing assistance accessing the full announcement at the time, the listed contact was the CDC Procurement and Grants Office (TIMS) via phone at 770-488-2700 or email at PGOTIM@cdc.gov.
Overall, this grant opportunity was designed to strengthen laboratory medicine quality by turning evidence into usable performance measures that capture where breakdowns commonly occur outside the analytic bench work, then using those measures to support measurable, reportable improvements in healthcare practice in a priority public health area.
Frequently Asked Questions (FAQs)
1) What is the name and funding opportunity number for this CDC grant?
The opportunity is titled "Evidence Based Laboratory Medicine Quality/Performance Measure Evaluation" and the Funding Opportunity Number is CDC RFA CI10-1004.
2) What was the main purpose of this funding opportunity?
The purpose was to improve the quality of clinical laboratory testing by developing and evaluating evidence-based quality or performance measures, then using those measures to drive practical quality improvement in healthcare delivery and support consistent measurement and reporting of performance data.
3) What parts of the laboratory testing process were the focus?
The focus was on the non-analytic portions of testing: the pre-analytic stage (before the test run) and the post-analytic stage (after the test run), rather than the analytic bench testing itself.
4) What activities are included in the pre-analytic stage?
Pre-analytic activities include steps such as ordering tests, collecting specimens, labeling, handling, transporting, and preparing samples.
5) What activities are included in the post-analytic stage?
Post-analytic activities include reporting results, communicating critical values, interpreting and acting on results, and ensuring appropriate follow-up.
6) What kind of work was CDC looking for in applications?
CDC was looking for targeted, high-value measurement work: developing, evaluating, validating, and supporting early implementation of evidence-based measures tied to real gaps in practice, where better tracking could plausibly lead to safer care, fewer errors, improved outcomes, or more efficient and reliable lab-supported clinical decision-making.
7) Did applicants need to cover many laboratory domains, or focus on one area?
Applicants were expected to concentrate on one focused area aligned with national healthcare priorities and with clear public health importance, rather than proposing broad, unfocused measurement across many laboratory domains.
8) How was this opportunity framed in terms of scope (quality improvement vs. other types of projects)?
The scope was limited to quality improvement associated with delivering healthcare and the measurement and reporting systems needed to monitor performance. It was not framed as basic science research, new test development, or unrelated laboratory infrastructure expansion.
9) What type of award mechanism was used?
This was offered as a discretionary cooperative agreement.
10) What does it mean that it was a cooperative agreement in this context?
A cooperative agreement typically means CDC anticipated substantial involvement during the project period, such as providing technical input, aligning work with national measurement frameworks, or coordinating across awardees.
11) How many awards were planned?
The program planned to make about three awards.
12) What was the estimated total funding amount?
The estimated total funding amount was $2,250,000.
13) What was the expected funding range per award?
Individual awards were expected to fall between $150,000 and $350,000.
14) What level of project scale did the funding level suggest?
The described funding level was positioned as mid-sized and appropriate for measure development, evaluation, validation, and early implementation work, rather than large-scale nationwide rollouts.
15) Who was eligible to apply?
Eligibility was broad and included: nonprofits (with or without 501(c)(3) status), universities and colleges, research institutions, hospitals, community-based and faith-based organizations, tribal governments and tribal organizations (including Alaska Native health corporations, Urban Indian health organizations, and Tribal epidemiology centers), and state and local governments along with their political subdivisions.
16) Could a bona fide agent apply on behalf of a state or local government?
Yes. The announcement allowed applications from bona fide agents applying on behalf of a state or local government.
17) Was any special documentation required for bona fide agents?
Yes. Submissions through Grants.gov required documentation confirming bona fide agent status, described as a letter from the relevant government entity.
18) Was cost sharing or matching funding required?
No. The opportunity specified that no cost sharing or matching funds were required.
19) When was the opportunity posted?
The opportunity was posted on May 24, 2010.
20) Was a letter of intent required, and when was it due?
A letter of intent was part of the timeline and was due June 21, 2010.
21) When were applications due?
The timeline listed an application submission date of July 2, 2010, and also listed the formal closing date and application deadline as July 7, 2010.
22) Is this funding opportunity still open?
No. The opportunity was later archived on August 6, 2010, indicating it was time-limited and is no longer open.
23) What was the overall goal for public health and healthcare delivery?
The overall goal was to strengthen laboratory medicine quality by turning evidence into usable performance measures that capture where breakdowns commonly occur outside the analytic bench work, then using those measures to support measurable, reportable improvements in healthcare practice in a priority public health area.
24) Who was the listed contact for assistance with the announcement?
The listed contact was the CDC Procurement and Grants Office (TIMS), reachable by phone at 770-488-2700 or by email at PGOTIM@cdc.gov.
Browse more opportunities from the same category: Health
Next opportunity: NCRR Science Education Partnership Award (SEPA) (R25)
Previous opportunity: Research Coordination Networks (RCN)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA CI10 1004
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA CI10 1004) also looked into and applied for these:
| Funding Opportunity |
|---|
| Promoting Immunization Through Targeted Stakeholders Apply for CDC RFA IP10 1003 Funding Number: CDC RFA IP10 1003 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $220,000 |
| Immunization Information Systems (IIS) Capacity Building Apply for CDC RFA IP10 1004 Funding Number: CDC RFA IP10 1004 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $520,000 |
| Developmental Behavioral Research Network Apply for HRSA 10 202 Funding Number: HRSA 10 202 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| APS for Biomedical Research for Reproductive Health Apply for APS OAA 10 000003 Funding Number: APS OAA 10 000003 Agency: Agency for International Development Category: Health Funding Amount: $28,000,000 |
| Medicaid Infrastructure Grant Apply for CMS 1QA 11 001 Funding Number: CMS 1QA 11 001 Agency: Centers for Medicare Medicaid Services Category: Health Funding Amount: $750,000 |
| Instructions for Preparing a Directed Source Award Application Apply for CDC RFA DD 10 1015E Funding Number: CDC RFA DD 10 1015E Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Core Centers for Musculoskeletal Biology and Medicine (P30) Apply for RFA AR 11 011 Funding Number: RFA AR 11 011 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
| Clinical Centers for the Severe Asthma Research Program (SARP) (U10) Apply for RFA HL 11 018 Funding Number: RFA HL 11 018 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Clinical Coordinating Center for the Severe Asthma Research Program (SARP) (U10) Apply for RFA HL 11 030 Funding Number: RFA HL 11 030 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NEI Clinical Vision Research (U10) Apply for PAR 10 207 Funding Number: PAR 10 207 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Instructions for Preparing a Directed Source Award Application Fiscal Year 2010 Apply for CDC RFA HK10 001E Funding Number: CDC RFA HK10 001E Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Next Generation PrEP (R01) Apply for RFA AI 10 012 Funding Number: RFA AI 10 012 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Management of Severe Febrile Illness Apply for USAID TANZANIA 10 008 RFA Funding Number: USAID TANZANIA 10 008 RFA Agency: Tanzania USAID Dar es Salaam Category: Health Funding Amount: $24,000,000 |
| Interstitial Cystitis Apply for CDC RFA DP10 1007 Funding Number: CDC RFA DP10 1007 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Demonstrating the Capacity of Comprehensive Cancer Control Programs to Implement Policy and Environmental Cancer Control Interventions Apply for CDC RFA DP10 1017 Funding Number: CDC RFA DP10 1017 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| National HIV Behavioral Surveillance For Young Men Who Have Sex With Men Apply for RFA PS 11 001 Funding Number: RFA PS 11 001 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $400,000 |
| The Community Based Doula Program Apply for HRSA 10 036 Funding Number: HRSA 10 036 Agency: Health Resources and Services Administration Category: Health Funding Amount: $295,583 |
| Public Health Support for Brownfield/Land Reuse and Legacy Sites in the Area of Concern (AOC) for the Great Lakes Apply for CDC RFA TS10 1003 Funding Number: CDC RFA TS10 1003 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $200,000 |
| Heart Failure Clinical Research Network Coordinating Center (U10) Apply for RFA HL 12 002 Funding Number: RFA HL 12 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Heart Failure Clinical Research Network Regional Clinical Centers (U10) Apply for RFA HL 12 001 Funding Number: RFA HL 12 001 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA CI10 1004", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.